SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-23-006625
Filing Date
2023-10-25
Accepted
2023-10-25 16:00:22
Documents
15
Period of Report
2023-10-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea187250-8k_optimizerx.htm   iXBRL 8-K 38846
2 COMMON STOCK PURCHASE AGREEMENT DATED OCTOBER 24, 2023 BY AND AMONG THE COMPANY ea187250ex10-1_optimizerx.htm EX-10.1 42471
3 PRESS RELEASE OF OPTIMIZERX DATED OCTOBER 25, 2023 ea187250ex99-1_optimizerx.htm EX-99.1 16258
4 GRAPHIC ex99-1_001.jpg GRAPHIC 5359
  Complete submission text file 0001013762-23-006625.txt   297195

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE oprx-20231020.xsd EX-101.SCH 3021
6 XBRL LABEL FILE oprx-20231020_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE oprx-20231020_pre.xml EX-101.PRE 22363
9 EXTRACTED XBRL INSTANCE DOCUMENT ea187250-8k_optimizerx_htm.xml XML 3303
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 231345655
SIC: 7389 Services-Business Services, NEC